Retrieve available abstracts of 166 articles: HTML format
Single Articles
May 2025
WANG Y, Qiao S, Wang P, Li M, et al Copper's new role in cancer: how cuproptosis-related genes could revolutionize
glioma treatment.
BMC Cancer. 2025;25:859. PubMedAbstract available
HAJIKARIMLOO B, Mohammadzadeh I, Tos SM, Habibi MA, et al Machine learning in prediction of epidermal growth factor receptor status in
non-small cell lung cancer brain metastases: a systematic review and
meta-analysis.
BMC Cancer. 2025;25:818. PubMedAbstract available
April 2025
WANG P, Wang J, Fang Z, Chen Q, et al Novel metabolic subtypes in IDH-mutant gliomas: implications for prognosis and
therapy.
BMC Cancer. 2025;25:815. PubMedAbstract available
LIU J, Guan X, Gao S, Quan L, et al Novel insight of critical genes involved in breast cancer brain metastasis:
evidence from a cross-tissue transcriptome association study and validation
through external clinical cohorts.
BMC Cancer. 2025;25:707. PubMedAbstract available
CHUNG MW, Tzeng CC, Huang YC, Wei KC, et al Neutrophil-to-lymphocyte ratio dynamics: prognostic value and potential for
surveilling glioblastoma recurrence.
BMC Cancer. 2025;25:709. PubMedAbstract available
ZHANG H, Wang Z, Qiao X, Wu J, et al Investigating potential drug targets for the treatment of glioblastoma: a
Mendelian randomization study.
BMC Cancer. 2025;25:654. PubMedAbstract available
YIN X, Lin X, Zhang G, Yin Y, et al Intensity-modulated proton therapy for hippocampal-sparing prophylactic cranial
irradiation: a planning comparison with photon therapy.
BMC Cancer. 2025;25:639. PubMedAbstract available
WANG S, Guo J, Xian X, Li M, et al Correction: Distinct 5-methylcytosine profiles of LncRNA in breast cancer brain
metastasis.
BMC Cancer. 2025;25:625. PubMed
ZHENG J, Wang Z, Zhu H, Guo W, et al Impact of transducer arrays on deep-seated dosimetry in radiotherapy with
concurrent TTFields for glioblastoma (extreme analysis).
BMC Cancer. 2025;25:600. PubMedAbstract available
March 2025
WANG S, Guo J, Xian X, Li M, et al Distinct 5-methylcytosine profiles of LncRNA in breast cancer brain metastasis.
BMC Cancer. 2025;25:557. PubMedAbstract available
CAO P, Jia X, Wang X, Fan L, et al Deep learning radiomics for the prediction of epidermal growth factor receptor
mutation status based on MRI in brain metastasis from lung adenocarcinoma
patients.
BMC Cancer. 2025;25:443. PubMedAbstract available
MAWHINNEY G, Higham H, Leedham S, Ansorge O, et al Study protocol for putting the 'Person' in the PiCTuRE: an exploratory sequential
mixed methods-based design, exploring how precision medicine is implemented and
experienced by people living with a primary tumour of the craniospinal axis.
BMC Cancer. 2025;25:420. PubMedAbstract available
LIANG L, Lv W, Cheng G, Gao M, et al Impact of celastrol on mitochondrial dynamics and proliferation in glioblastoma.
BMC Cancer. 2025;25:412. PubMedAbstract available
INGGAS MAM, Patel U, Wijaya JH, Otinashvili N, et al The role of temozolomide as adjuvant therapy in glioblastoma management: a
systematic review and meta-analysis.
BMC Cancer. 2025;25:399. PubMedAbstract available
February 2025
SCHNEIDER M, Potthoff AL, Ahmadipour Y, Borger V, et al The ATLAS/NOA-29 study protocol: a phase III randomized controlled trial of
anterior temporal lobectomy versus gross-total resection in newly-diagnosed
temporal lobe glioblastoma.
BMC Cancer. 2025;25:306. PubMedAbstract available
YANG X, Song Y, Xu R, Yang Y, et al Prophylactic cranial irradiation improved the prognosis in pT1-2N0M0 small cell
lung cancers after complete resection: a retrospective real-world study.
BMC Cancer. 2025;25:266. PubMedAbstract available
DEGUCHI S, Ohka F, Shiba Y, Yamaguchi J, et al Investigator-initiated phase I trial of an oligonucleotide therapeutic targeting
long noncoding RNA TUG 1 for recurrent glioblastoma.
BMC Cancer. 2025;25:251. PubMedAbstract available
WU D, Huang Y, Wang B, Zheng Q, et al A clinical model to predict brain metastases in resected early-stage non-small
cell lung cancer.
BMC Cancer. 2025;25:236. PubMedAbstract available
ZHANG C, Lv Z, Liang H, Hu F, et al Bioinformatics insights into ACSL1 and ACSL5: prognostic and immune roles in
low-grade glioma.
BMC Cancer. 2025;25:226. PubMedAbstract available
REZANEJAD-ASL P, Parhizkar Roudsari P, Rezaei N, Sharafkhah M, et al Pre-diagnostic risk factors for brain cancer incidence and survival: insights
from the Golestan Cohort Study.
BMC Cancer. 2025;25:210. PubMedAbstract available
January 2025
ZHOU Z, Liu J, Yue Q, Chen L, et al Optimal treatment approach for intracranial germinoma: a systematic review and
meta-analysis.
BMC Cancer. 2025;25:26. PubMedAbstract available
December 2024
LESUEUR P, Clarisse B, Lequesne J, Licaj I, et al Proton therapy versus conventional radiotherapy for the treatment of cavernous
sinus benign meningioma, a randomized controlled phase III study protocol
(COG-PROTON-01).
BMC Cancer. 2024;24:1594. PubMedAbstract available
POURSAEED R, Mohammadzadeh M, Safaei AA Survival prediction of glioblastoma patients using machine learning and deep
learning: a systematic review.
BMC Cancer. 2024;24:1581. PubMedAbstract available
DENG G, Zhang Q, Fan J, Zhao C, et al Optimal intervention timing for craniocerebral radiotherapy in EGFR mutant lung
adenocarcinoma patients with brain metastases.
BMC Cancer. 2024;24:1571. PubMedAbstract available
ZHANG LY, Du HZ, Lu TT, Song SH, et al Long-term outcome of childhood and adolescent patients with craniopharyngiomas: a
single center retrospective experience.
BMC Cancer. 2024;24:1555. PubMedAbstract available
PRADO MB, Coelho BP, Iglesia RP, Alves RN, et al Prion protein regulates invasiveness in glioblastoma stem cells.
BMC Cancer. 2024;24:1539. PubMedAbstract available
ZHANG X, Sun Q, Chen R, Zhao M, et al Efficacy and safety of combining anti-angiogenic therapy, radiotherapy, and PD-1
inhibitors in patients with driver gene-negative non-small cell lung cancer brain
metastases: a retrospective study.
BMC Cancer. 2024;24:1492. PubMedAbstract available
ROSSI J, Cavallieri F, Bassi MC, Venturelli F, et al To be or not to be: The dilemma over the prognostic role of epilepsy at
presentation in patients with glioblastoma - a systematic review and
meta-analysis.
BMC Cancer. 2024;24:1488. PubMedAbstract available
November 2024
HAJIKARIMLOO B, Habibi MA, Kooshki A, Alvani MS, et al Dabrafenib plus trametinib in low-grade versus high-grade gliomas: a systematic
review and meta-analysis.
BMC Cancer. 2024;24:1473. PubMedAbstract available
DAVE B, Tailor J Human stem cell models to unravel brain cancer.
BMC Cancer. 2024;24:1465. PubMedAbstract available
LEE D, Lee E, Roh TH, Kim SH, et al Optimal timing of chemoradiation after resection or biopsy of glioblastomas: a
nationwide population-based study.
BMC Cancer. 2024;24:1450. PubMedAbstract available
GU J, Huang X, Zhang Y, Bao C, et al Cerebrospinal fluid IL-6 and IL-10 as promising diagnostic and therapeutic
prognostic biomarkers for secondary central nervous system lymphoma.
BMC Cancer. 2024;24:1443. PubMedAbstract available
HE Q, Wang W, Xu D, Xiong Y, et al Genetic association between mitochondrial DNA copy number and glioma risk:
insights from causality.
BMC Cancer. 2024;24:1439. PubMedAbstract available
October 2024
WANG T, Li R, Liu S, Wu Q, et al The effects of immune checkpoint inhibitors vs. chemotherapy combined with brain
radiotherapy in non-small cell lung cancer patients with brain metastases.
BMC Cancer. 2024;24:1343. PubMedAbstract available
TONG Y, Wan X, Yin C, Lei T, et al In-depth exploration of the focus issues of TKI combined with radiotherapy for
EGFR-mutant lung adenocarcinoma patients with brain metastasis: a systematic
analysis based on literature metrology, meta-analysis, and real-world
observational data.
BMC Cancer. 2024;24:1305. PubMedAbstract available
WANG Y, Xu H, Sa Q, Li L, et al Development of graded prognostic assessment for breast Cancer brain metastasis
incorporating extracranial metastatic features: a retrospective analysis of 284
patients.
BMC Cancer. 2024;24:1262. PubMedAbstract available
GAO L, Zhang R, Zhang W, Lan Y, et al Integrated bioinformatics analysis and experimental validation on malignant
progression and immune cell infiltration of LTBP2 in gliomas.
BMC Cancer. 2024;24:1252. PubMedAbstract available
September 2024
MOON HH, Park JE, Kim N, Kim YH, et al Prospective longitudinal analysis of imaging-based spatiotemporal tumor habitats
in glioblastoma, IDH-wild type: implication in patient outcome using
multiparametric physiologic MRI.
BMC Cancer. 2024;24:1197. PubMedAbstract available
RUSSO R, Verdolotti T, Perna A, Ruscelli L, et al Central nervous system pediatric multi-disciplinary tumor board: a single center
experience.
BMC Cancer. 2024;24:1146. PubMedAbstract available
KHADHRAOUI E, Schmidt L, Klebingat S, Schwab R, et al Comparison of a new MR rapid wash-out map with MR perfusion in brain tumors.
BMC Cancer. 2024;24:1139. PubMedAbstract available
BAO H, Chen Y, Meng Z, Chu Z, et al The causal relationship between CSF metabolites and GBM: a two-sample mendelian
randomization analysis.
BMC Cancer. 2024;24:1119. PubMedAbstract available
AFSORDEH N, Pournajaf S, Bayat H, Mohajerani F, et al Eslicarbazepine induces apoptosis and cell cycle arrest in C6 glioma cells in
vitro and suppresses tumor growth in an intracranial rat model.
BMC Cancer. 2024;24:1099. PubMedAbstract available
August 2024
TIAN Y, Gao X, Yang X, Chen S, et al VEGFA contributes to tumor property of glioblastoma cells by promoting
differentiation of myeloid-derived suppressor cells.
BMC Cancer. 2024;24:1040. PubMedAbstract available
HOSOYA K, Ozasa H, Tanji M, Yoshida H, et al Performance status improvement and advances in systemic treatment after brain
metastases resection: a retrospective single-center cohort study of non-small
cell lung cancer patients.
BMC Cancer. 2024;24:1030. PubMedAbstract available
YAN J, Guo C, Zheng H, Li Y, et al Noninvasive prediction of BRAF V600E mutation status of pleomorphic
xanthoastrocytomas with MRI morphologic features and diffusion-weighted imaging.
BMC Cancer. 2024;24:1022. PubMedAbstract available
WEI R, Zhou J, Bui B, Liu X, et al Glioma actively orchestrate a self-advantageous extracellular matrix to promote
recurrence and progression.
BMC Cancer. 2024;24:974. PubMedAbstract available
YU J, Fu J, Li Y, Hu G, et al Hypopituitarism after gamma knife radiosurgery for pituitary adenomas: long-term
results from a single-center experience.
BMC Cancer. 2024;24:963. PubMedAbstract available
YAO N, Qin Z, Chen M, Hu L, et al Effects of brain radiotherapy strategies on survival in the era of MRI for
patients with limited stage small cell lung cancer.
BMC Cancer. 2024;24:953. PubMedAbstract available
HIROSE T, Deguchi S, Yasui K, Inoue M, et al The indication of palliative whole-brain radiotherapy for patients with brain
metastases: a simple prognostic scoring system in the era of stereotactic
radiosurgery.
BMC Cancer. 2024;24:940. PubMedAbstract available
WANG J, Zheng Q, Wang Y, Wang C, et al Dosimetric comparison of ZAP-X, Gamma Knife, and CyberKnife stereotactic
radiosurgery for single brain metastasis.
BMC Cancer. 2024;24:936. PubMedAbstract available
July 2024
ZOTO MUSTAFAYEV T, Turna M, Bolukbasi Y, Tezcanli E, et al Clinical and radiological effects of Bevacizumab for the treatment of
radionecrosis after stereotactic brain radiotherapy.
BMC Cancer. 2024;24:918. PubMedAbstract available
LI Z, Wang J, Deng L, Zhai Y, et al Hippocampal avoidance whole-brain radiotherapy with simultaneous integrated boost
in lung cancer brain metastases and utility of the Hopkins verbal learning test
for testing cognitive impairment in Chinese patients: a prospective phase II
study.
BMC Cancer. 2024;24:899. PubMedAbstract available
DUAN Y, Wang Y, Zhang X, Huang J, et al Prevalence of dysphagia following posterior fossa tumor resection: a systematic
review and meta?analysis.
BMC Cancer. 2024;24:896. PubMedAbstract available
BICKERDIKE MJ, Nafia I, Bessede A, Chen CB, et al AT-0174, a novel dual IDO1/TDO2 enzyme inhibitor, synergises with temozolomide to
improve survival in an orthotopic mouse model of glioblastoma.
BMC Cancer. 2024;24:889. PubMedAbstract available
ROH YH, Park JE, Park SY, Cho YH, et al Assessment of imaging risks for recurrence after stereotactic radiosurgery for
brain metastases (IRRaS-BM).
BMC Cancer. 2024;24:866. PubMedAbstract available
LI X, Zhang Y, Ye Y, Tian S, et al Carbon-ion radiotherapy alone vs. standard dose photon radiation with carbon-ion
radiotherapy boost for high-grade gliomas: a retrospective study.
BMC Cancer. 2024;24:837. PubMedAbstract available
CHANG T, Zhang R, Gan J, Yang Y, et al Investigating distinct clinical features and constructing a nomogram model for
survival probability in adults with cerebellar high-grade gliomas.
BMC Cancer. 2024;24:836. PubMedAbstract available
LI YA, Zhao C, Ge JJ, Li C, et al Correction: Apatinib combined with temozolomide in diffuse midline glioma: a
novel and effective therapy.
BMC Cancer. 2024;24:829. PubMed
XIE X, Luo C, Wu S, Qiao W, et al Recursive partitioning analysis for survival stratification and early imaging
prediction of molecular biomarker in glioma patients.
BMC Cancer. 2024;24:818. PubMedAbstract available
SU Y, Cheng R, Guo J, Zhang M, et al Differentiation of glioma and solitary brain metastasis: a multi-parameter
magnetic resonance imaging study using histogram analysis.
BMC Cancer. 2024;24:805. PubMedAbstract available
XIAO Y, Wu W, Liu F, Jia Y, et al The clinical significance of inflammatory mediators in predicting obesity and
progression-free survival in patients with adult-onset Craniopharyngioma.
BMC Cancer. 2024;24:799. PubMedAbstract available
June 2024
LI YA, Zhao C, Ge JJ, Li C, et al Apatinib combined with temozolomide in diffuse midline glioma: a novel and
effective therapy.
BMC Cancer. 2024;24:754. PubMedAbstract available
LAKOMY R, Lojova M, Souckova L, Hynkova L, et al (11)C-methionine in the diagnostics and management of glioblastoma patients with
rapid early progression: nonrandomized, open label, prospective clinical trial
(GlioMET).
BMC Cancer. 2024;24:736. PubMedAbstract available
LIU ZY, Tang F, Wang J, Yang JZ, et al Serum beta2-microglobulin acts as a biomarker for severity and prognosis in
glioma patients: a preliminary clinical study.
BMC Cancer. 2024;24:692. PubMedAbstract available
May 2024
ZHANG LY, Guo W, Du HZ, Pan H, et al Brachytherapy in craniopharyngiomas: a systematic review and meta-analysis of
long-term follow-up.
BMC Cancer. 2024;24:637. PubMedAbstract available
AZIMI P, Yazdanian T, Ahmadiani A mRNA markers for survival prediction in glioblastoma multiforme patients: a
systematic review with bioinformatic analyses.
BMC Cancer. 2024;24:612. PubMedAbstract available
WANG J, Wang G, Cheng L, Zhu H, et al Preoperative peripheral inflammatory markers are predictors of postoperative
central diabetes insipidus in craniopharyngioma patients: a retrospective study.
BMC Cancer. 2024;24:572. PubMedAbstract available
April 2024
KUMTHEKAR P, Lyleroehr M, Lacson L, Lukas RV, et al A qualitative evaluation of factors influencing Tumor Treating fields (TTFields)
therapy decision making among brain tumor patients and physicians.
BMC Cancer. 2024;24:527. PubMedAbstract available
LIU C, Liu F, Nie D, Xiao Y, et al Gut microbiota composition and metabolic characteristics in patients with
Craniopharyngioma.
BMC Cancer. 2024;24:521. PubMedAbstract available
DVORAKOVA K, Skarkova V, Vitovcova B, Soukup J, et al Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma
patients.
BMC Cancer. 2024;24:509. PubMedAbstract available
SHI MX, Ding X, Tang L, Cao WJ, et al PROTAC EZH2 degrader-1 overcomes the resistance of podophyllotoxin derivatives in
refractory small cell lung cancer with leptomeningeal metastasis.
BMC Cancer. 2024;24:504. PubMedAbstract available
ORESKOVIC D, Madero Pohlen A, Cvitkovic I, Alen JF, et al Chronic hyperglycemia and intracranial meningiomas.
BMC Cancer. 2024;24:488. PubMedAbstract available
DENG MY, da Silva AS, Goller PC, Konig L, et al Plasma extracellular vesicles in meningioma patients following radiotherapy as
liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07).
BMC Cancer. 2024;24:449. PubMedAbstract available
KONG C, Yin X, Zou J, Ma C, et al The application of different machine learning models based on PET/CT images and
EGFR in predicting brain metastasis of adenocarcinoma of the lung.
BMC Cancer. 2024;24:454. PubMedAbstract available
CHEN M, Li R, Kong Y, Shi L, et al Rational and design of prophylactic cranial irradiation (PCI) and brain MRI
surveillance versus brain MRI surveillance alone in patients with limited-stage
small cell lung cancer achieving complete remission (CR) of tumor after
chemoradiotherapy: a mu
BMC Cancer. 2024;24:429. PubMedAbstract available
March 2024
WANG G, Ren X, Li J, Cui R, et al High expression of RTEL1 predicates worse progression in gliomas and promotes
tumorigenesis through JNK/ELK1 cascade.
BMC Cancer. 2024;24:385. PubMedAbstract available
ZHANG W, Blank A, Kremenetskaia I, Nitzsche A, et al CD13 expression affects glioma patient survival and influences key functions of
human glioblastoma cell lines in vitro.
BMC Cancer. 2024;24:369. PubMedAbstract available
QI H, Hou Y, Zheng Z, Zheng M, et al Clinical characteristics and MRI based radiomics nomograms can predict iPFS and
short-term efficacy of third-generation EGFR-TKI in EGFR-mutated lung
adenocarcinoma with brain metastases.
BMC Cancer. 2024;24:362. PubMedAbstract available
MA Y, Gong Y, Qiu Q, Ma C, et al Research on multi-model imaging machine learning for distinguishing early
hepatocellular carcinoma.
BMC Cancer. 2024;24:363. PubMedAbstract available
HUANG Y, Wu Z, Peng Z, Liu A, et al Hsa_circ_0004872 alleviates meningioma progression by sponging miR-190a-3p/PTEN
signaling.
BMC Cancer. 2024;24:345. PubMedAbstract available
ROUTMAN DM, Jusue-Torres I, Brown PD, Trifiletti DM, et al Pre-operative vs. post-operative stereotactic radiosurgery for operative
metastatic brain tumors: study protocol for a phase III clinical trial.
BMC Cancer. 2024;24:332. PubMedAbstract available
MENG J, Qian W, Yang Z, Gong L, et al p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme.
BMC Cancer. 2024;24:317. PubMedAbstract available
February 2024
SUN L, Jin X, Xie L, Xu G, et al Retraction Note: Swainsonine represses glioma cell proliferation, migration and
invasion by reduction of miR-92a expression.
BMC Cancer. 2024;24:275. PubMed
QIAO W, Wang Y, Luo C, Wu J, et al Development of preoperative and postoperative models to predict recurrence in
postoperative glioma patients: a longitudinal cohort study.
BMC Cancer. 2024;24:274. PubMedAbstract available
KINO S, Kanamori M, Shimoda Y, Niizuma K, et al Distinguishing IDH mutation status in gliomas using FTIR-ATR spectra of
peripheral blood plasma indicating clear traces of protein amyloid aggregation.
BMC Cancer. 2024;24:222. PubMedAbstract available
BEN-ZION BERLINER M, Yust-Katz S, Lavie I, Goldberg Y, et al Central nervous system metastases in breast cancer patients with germline BRCA
pathogenic variants compared to non-carriers: a matched-pair analysis.
BMC Cancer. 2024;24:219. PubMedAbstract available
LI G, Ma L, Feng C, Yin H, et al MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in
glioblastoma.
BMC Cancer. 2024;24:220. PubMedAbstract available
BOCCACINO JM, Dos Santos Peixoto R, Fernandes CFL, Cangiano G, et al Integrated transcriptomics uncovers an enhanced association between the prion
protein gene expression and vesicle dynamics signatures in glioblastomas.
BMC Cancer. 2024;24:199. PubMedAbstract available
SHIM YB, Oh BC, Lee EK, Park MH, et al Comparison of partitioned survival modeling with state transition modeling
approaches with or without consideration of brain metastasis: a case study of
Osimertinib versus pemetrexed-platinum.
BMC Cancer. 2024;24:189. PubMedAbstract available
PHAM CP, Nguyen TTH, Do AT, Nguyen TK, et al A real-world cohort study of first-line afatinib in patients with EGFR-mutant
advanced non-small cell lung cancer in Vietnam.
BMC Cancer. 2024;24:176. PubMedAbstract available
LIAO L, Tang J, Hong Z, Jiang W, et al The effects of
oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with
mismatch repair-deficient: a retrospective study.
BMC Cancer. 2024;24:164. PubMedAbstract available
January 2024
ZHANG X, Li Y, Zhang G, Ma C, et al Temporal trend in hospitalizations for malignant neoplasm and benign neoplasm: a
nationwide study, China, 2004-2020.
BMC Cancer. 2024;24:154. PubMedAbstract available
VAN TILBURG CM, Kilburn LB, Perreault S, Schmidt R, et al LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in
pediatric and young adult patients with newly diagnosed low-grade glioma
harboring an activating RAF alteration.
BMC Cancer. 2024;24:147. PubMedAbstract available
YU W, Zhou M, Niu H, Li J, et al Prognostic marker CXCL5 in glioblastoma polyformis and its mechanism of immune
invasion.
BMC Cancer. 2024;24:140. PubMedAbstract available
YAO B, Wang H, Wu X, Wang C, et al A system review of central nervous system tumors on children in China:
epidemiology and clinical characteristics.
BMC Cancer. 2024;24:138. PubMedAbstract available
HEUER S, Burghaus I, Gose M, Kessler T, et al PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in
patients with progressive glioblastoma.
BMC Cancer. 2024;24:135. PubMedAbstract available
LU Y, Liao L, Du K, Mo J, et al Clinical activity and safety of sintilimab, bevacizumab, and TMZ in patients with
recurrent glioblastoma.
BMC Cancer. 2024;24:133. PubMedAbstract available
LIU JS, Cai YX, He YZ, Xu J, et al Spatial and temporal heterogeneity of tumor immune microenvironment between
primary tumor and brain metastases in NSCLC.
BMC Cancer. 2024;24:123. PubMedAbstract available
QIAN J, He Z, Wu Y, Li H, et al Analysis of the efficacy of upfront brain radiotherapy versus deferred
radiotherapy for EGFR/ALK-positive non-small cell lung cancer with brain
metastases: a retrospective study.
BMC Cancer. 2024;24:117. PubMedAbstract available
YANG W, Han Y, He C, Zhong S, et al Association between psychiatric disorders and glioma risk: evidence from
Mendelian randomization analysis.
BMC Cancer. 2024;24:118. PubMedAbstract available
ZHU X, Liu Y, Guo W, Liang Q, et al Epidemiology, characteristics, and prognostic factors of lymphoplasmacyte-rich
meningioma: a systematic literature review.
BMC Cancer. 2024;24:110. PubMedAbstract available
LI L, Xia S, Zhao Z, Deng L, et al EMP3 as a prognostic biomarker correlates with EMT in GBM.
BMC Cancer. 2024;24:89. PubMedAbstract available
ZUCHEGNA C, Leone S, Romano A, Porcellini A, et al KRAS is a molecular determinant of platinum responsiveness in glioblastoma.
BMC Cancer. 2024;24:77. PubMedAbstract available
MASTALL M, Roth P, Bink A, Fischer Maranta A, et al A phase Ib/II randomized, open-label drug repurposing trial of glutamate
signaling inhibitors in combination with chemoradiotherapy in patients with newly
diagnosed glioblastoma: the GLUGLIO trial protocol.
BMC Cancer. 2024;24:82. PubMedAbstract available
BHASKARAN D, Savage J, Patel A, Collinson F, et al A randomised phase II trial of temozolomide with or without cannabinoids in
patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre,
double-blind, placebo-controlled trial.
BMC Cancer. 2024;24:83. PubMedAbstract available
HUANG CY, Bai MH, Shen JW, Sun QQ, et al Anus preservation in low rectal adenocarcinoma based on MMR/MSI status (APRAM): a
study protocol for a randomised, controlled, open-label, multicentre phase III
trial.
BMC Cancer. 2024;24:57. PubMedAbstract available
SUN Y, Liu P, Wang Z, Zhang H, et al Efficacy and indications of gamma knife radiosurgery for recurrent low-and
high-grade glioma.
BMC Cancer. 2024;24:37. PubMedAbstract available
CRUCITTA S, Pasqualetti F, Gonnelli A, Ruglioni M, et al IDH1 mutation is detectable in plasma cell-free DNA and is associated with
survival outcome in glioma patients.
BMC Cancer. 2024;24:31. PubMedAbstract available
MOHAJERANI F, Tehrankhah ZM, Rahmani S, Afsordeh N, et al CLEC19A overexpression inhibits tumor cell proliferation/migration and promotes
apoptosis concomitant suppression of PI3K/AKT/NF-kappaB signaling pathway in
glioblastoma multiforme.
BMC Cancer. 2024;24:19. PubMedAbstract available
OUDIN A, Moreno-Sanchez PM, Baus V, Niclou SP, et al Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors
in patient-derived orthotopic xenografts leads to clinically relevant tumor
recurrence.
BMC Cancer. 2024;24:3. PubMedAbstract available
ZHAO S, Zhang M, Zhang Q, Wu J, et al Anlotinib alone or in combination with bevacizumab in the treatment of recurrent
high-grade glioma: a prospective single-arm, open-label phase II trial.
BMC Cancer. 2024;24:6. PubMedAbstract available
December 2023
DAI L, Zhou P, Lyu L, Jiang S, et al Systematic analysis based on the cuproptosis-related genes identifies ferredoxin
1 as an immune regulator and therapeutic target for glioblastoma.
BMC Cancer. 2023;23:1249. PubMedAbstract available
ZHANG K, Zhang T, Guo Z, Zhao F, et al Adding simultaneous integrated boost to whole brain radiation therapy improved
intracranial tumour control and minimize radiation-induced brain injury risk for
the treatment of brain metastases.
BMC Cancer. 2023;23:1240. PubMedAbstract available
ADEGBOYEGA B, Joseph A, Alabi A, Omomila J, et al Patient reported outcomes following whole brain radiotherapy in patients with
brain metastases in NSIA-LUTH Cancer Center.
BMC Cancer. 2023;23:1233. PubMedAbstract available
BAI J, He M, Gao E, Yang G, et al Radiomic texture analysis based on neurite orientation dispersion and density
imaging to differentiate glioblastoma from solitary brain metastasis.
BMC Cancer. 2023;23:1231. PubMedAbstract available
November 2023
SENRUNG A, Tripathi T, Yadav J, Janjua D, et al In vivo antiangiogenic effect of nimbolide, trans-chalcone and piperine for use
against glioblastoma.
BMC Cancer. 2023;23:1173. PubMedAbstract available
ZHANG Y, Wu X, Zhu J, Lu R, et al Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced
ferroptosis SLC39A14 knockdown inhibits glioma progression.
BMC Cancer. 2023;23:1120. PubMedAbstract available
October 2023
SONG Y, Lin S, Chen J, Dang J, et al First-line treatment with TKI plus brain radiotherapy versus TKI alone in
EGFR-mutated non-small cell Lung cancer with brain metastases: a systematic
review and meta-analysis.
BMC Cancer. 2023;23:1043. PubMedAbstract available
WEI D, Niu B, Zhai B, Liu XB, et al Expression profiles and function prediction of tRNA-derived fragments in glioma.
BMC Cancer. 2023;23:1015. PubMedAbstract available
YANG XS, Zhu P, Xie RX, Chen PF, et al Tracking tumor alteration in glioma through serum fibroblast activation protein
combined with image.
BMC Cancer. 2023;23:1012. PubMedAbstract available
ROZATI H, Chen J, Williams M Overall survival following stereotactic radiosurgery for ten or more brain
metastases: a systematic review and meta-analysis.
BMC Cancer. 2023;23:1004. PubMedAbstract available
WANG Z, Cui Y, Wang F, Xu L, et al DNA methylation-regulated LINC02587 inhibits ferroptosis and promotes the
progression of glioma cells through the CoQ-FSP1 pathway.
BMC Cancer. 2023;23:989. PubMedAbstract available
VINCENT CA, Nissen I, Dakhel S, Hornblad A, et al Epigenomic perturbation of novel EGFR enhancers reduces the proliferative and
invasive capacity of glioblastoma and increases sensitivity to temozolomide.
BMC Cancer. 2023;23:945. PubMedAbstract available
ROBINSON SD, Samuels M, Jones W, Gilbert D, et al Shooting the messenger: a systematic review investigating extracellular vesicle
isolation and characterisation methods and their influence on understanding
extracellular vesicles-radiotherapy interactions in glioblastoma.
BMC Cancer. 2023;23:939. PubMedAbstract available
MING Y, Luo C, Ji B, Cheng J, et al ARPC5 acts as a potential prognostic biomarker that is associated with cell
proliferation, migration and immune infiltrate in gliomas.
BMC Cancer. 2023;23:937. PubMedAbstract available
September 2023
CHENG WY, Shen CC, Liang YJ, Chiao MT, et al Polymorphism at codon 31 of CDKN1A (p21) as a predictive factor for bevacizumab
therapy in glioblastoma multiforme.
BMC Cancer. 2023;23:886. PubMedAbstract available
HATTORI EY, Arakawa Y, Mineharu Y, Furukawa K, et al Seizure control by adding on other anti-seizure medication on seizure during
levetiracetam administration in patients with glioma-related epilepsy.
BMC Cancer. 2023;23:849. PubMedAbstract available
SHAN E, Cao YN, Zhang Y, Chen W, et al Integrated profiling identifies CACNG3 as a prognostic biomarker for patients
with glioma.
BMC Cancer. 2023;23:846. PubMedAbstract available
LIU Z, Hong X, Wang L, Ma Z, et al Radiomic features from multiparametric magnetic resonance imaging predict
molecular subgroups of pediatric low-grade gliomas.
BMC Cancer. 2023;23:848. PubMedAbstract available
August 2023
MIRANDA J, Vazquez-Blomquist D, Bringas R, Fernandez-de-Cossio J, et al A co-formulation of interferons alpha2b and gamma distinctively targets cell
cycle in the glioblastoma-derived cell line U-87MG.
BMC Cancer. 2023;23:806. PubMedAbstract available
TAN C, Wei J, Li Z, Tian N, et al Circ_0021350 plays an oncogene role by regulating miR-1207-3p/PIK3R3 in
glioblastoma.
BMC Cancer. 2023;23:808. PubMedAbstract available
WANG X, Chen J, Lei Z, Chen H, et al Propensity score-matched analysis comparing hippocampus-avoidance whole-brain
radiotherapy plus simultaneous integrated boost with hippocampus‑avoidance
whole-brain radiotherapy alone for multiple brain metastases-a retrospective
study in multiple i
BMC Cancer. 2023;23:796. PubMedAbstract available
NEUTEL CLG, Viozzi I, Overduin CG, Rijpma A, et al Study protocol for a multicenter randomised controlled trial on the
(cost)effectiveness of biopsy combined with same-session MR-guided LITT versus
biopsy alone in patients with primary irresectable glioblastoma (EMITT trial).
BMC Cancer. 2023;23:788. PubMedAbstract available
SOUSA N, Geiss C, Bindila L, Lieberwirth I, et al Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II
overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: effects
on cell death, self-renewal, and invasion.
BMC Cancer. 2023;23:762. PubMedAbstract available
ZHAO N, Weng S, Liu Z, Xu H, et al CRISPR-Cas9 identifies growth-related subtypes of glioblastoma with therapeutical
significance through cell line knockdown.
BMC Cancer. 2023;23:749. PubMedAbstract available
ZHONG K, Shi Y, Gao Y, Zhang H, et al First-line induction chemotherapy with high-dose methotrexate versus teniposide
in patients with newly diagnosed primary central nervous system lymphoma: a
retrospective, multicenter cohort study.
BMC Cancer. 2023;23:746. PubMedAbstract available
LI J, Guo Q, Xing R Construction and validation of an immune infiltration-related risk model for
predicting prognosis and immunotherapy response in low grade glioma.
BMC Cancer. 2023;23:727. PubMedAbstract available
July 2023
TAN Q, Wang Q, Jin S, Zhou F, et al Network Evolution Model-based prediction of tumor mutation burden from
radiomic-clinical features in endometrial cancers.
BMC Cancer. 2023;23:712. PubMedAbstract available
CHIEN CH, Lai CC, Chuang JY, Chu JM, et al Role of SH3GLB1 in the regulation of CD133 expression in GBM cells.
BMC Cancer. 2023;23:713. PubMedAbstract available
WALTENBERGER M, Bernhardt D, Diehl C, Gempt J, et al Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction
stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after
surgical resection (SATURNUS): study protocol for a randomized phase III trial.
BMC Cancer. 2023;23:709. PubMedAbstract available
TAO R, Huang R, Yang J, Wang J, et al Comprehensive analysis of the clinical and biological significances of
cholesterol metabolism in lower-grade gliomas.
BMC Cancer. 2023;23:692. PubMedAbstract available
YUEYANG M, Yaqin H, Guolian X, Wenjian Z, et al Glioma angiogenesis is boosted by ELK3 activating the HIF-1[Formula: see
text]/VEGF-A signaling axis.
BMC Cancer. 2023;23:662. PubMedAbstract available
June 2023
PENG Y, Liu H, Wu Q, Wang L, et al Integrated bioinformatics analysis and experimental validation reveal ISG20 as a
novel prognostic indicator expressed on M2 macrophage in glioma.
BMC Cancer. 2023;23:596. PubMedAbstract available
XUE Z, Wang J, Wang Z, Liu J, et al SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT
signaling pathway.
BMC Cancer. 2023;23:589. PubMedAbstract available
SUN S, Yang C, Wang K, Huang R, et al Molecular and clinical characterization of PTRF in glioma via 1,022 samples.
BMC Cancer. 2023;23:551. PubMedAbstract available
WEI L, Pan M, Jiang Q, Hu B, et al Eukaryotic initiation factor 4 A-3 promotes glioblastoma growth and invasion
through the Notch1-dependent pathway.
BMC Cancer. 2023;23:550. PubMedAbstract available
FU M, Zhou Z, Huang X, Chen Z, et al Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map.
BMC Cancer. 2023;23:544. PubMedAbstract available
HAO Z, Huajun S, Zhen G, Yu X, et al AQP8 promotes glioma proliferation and growth, possibly through the ROS/PTEN/AKT
signaling pathway.
BMC Cancer. 2023;23:516. PubMedAbstract available
BABAZADEH SM, Zolfaghari MR, Zargar M, Baesi K, et al Interleukin-24-mediated antitumor effects against human glioblastoma via
upregulation of P38 MAPK and endogenous TRAIL-induced apoptosis and LC3-II
activation-dependent autophagy.
BMC Cancer. 2023;23:519. PubMedAbstract available
May 2023
AKANDA MR, Ahn EJ, Kim YJ, Salam SMA, et al Analysis of stromal PDGFR-beta and alpha-SMA expression and their clinical relevance in
brain metastases of breast cancer patients.
BMC Cancer. 2023;23:468. PubMedAbstract available
CHEN Y, Ma F, Zhang Z, Guo Y, et al LncRNA-PVT1 was identified as a key regulator for TMZ resistance and STAT-related
pathway in glioma.
BMC Cancer. 2023;23:455. PubMedAbstract available
DUAN X, Yang B, Zhao C, Tie B, et al Prognostic value of preoperative hematological markers in patients with
glioblastoma multiforme and construction of random survival forest model.
BMC Cancer. 2023;23:432. PubMedAbstract available
LIU ZY, Lan T, Tang F, He YZ, et al ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for
patients with glioma.
BMC Cancer. 2023;23:420. PubMedAbstract available
WANG X, Zhang H, Zhang M, Zhang X, et al Proteogenomic characterization of ferroptosis regulators reveals therapeutic
potential in glioblastoma.
BMC Cancer. 2023;23:415. PubMedAbstract available
ZOU R, Zhong X, Liang K, Zhi C, et al Elevated LILRB1 expression predicts poor prognosis and is associated with tumor
immune infiltration in patients with glioma.
BMC Cancer. 2023;23:403. PubMedAbstract available
April 2023
THIVAT E, Casile M, Moreau J, Molnar I, et al Phase I/II study testing the combination of AGuIX nanoparticles with
radiochemotherapy and concomitant temozolomide in patients with newly diagnosed
glioblastoma (NANO-GBM trial protocol).
BMC Cancer. 2023;23:344. PubMedAbstract available
ZHOU T, Zhu S, Xiong Q, Gan J, et al Intrathecal chemotherapy combined with systemic therapy in patients with
refractory leptomeningeal metastasis of non-small cell lung cancer: a
retrospective study.
BMC Cancer. 2023;23:333. PubMedAbstract available
KELLER KM, Koetsier J, Schild L, Amo-Addae V, et al The potential of PARP as a therapeutic target across pediatric solid
malignancies.
BMC Cancer. 2023;23:310. PubMedAbstract available
March 2023
WANG H, Xing R, Li M, Zhang M, et al Clinical efficacy and prognosis analysis of treatment regimens for EGFR mutant
non-small cell lung cancer and brain metastasis: a retrospective study.
BMC Cancer. 2023;23:289. PubMedAbstract available
CROUZEN JA, Petoukhova AL, Broekman MLD, Fiocco M, et al SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with
fractionated stereotactic radiosurgery for brain metastases.
BMC Cancer. 2023;23:273. PubMedAbstract available
KING AL, Acquaye-Mallory AA, Vera E, Mendoza T, et al Feasibility and preliminary efficacy of a virtual reality intervention targeting
distress and anxiety in primary brain tumor patients at the time of clinical
evaluation: Study protocol for a phase 2 clinical trial.
BMC Cancer. 2023;23:262. PubMedAbstract available
LIU X, Li Z, Sun J, Zhang Z, et al Interaction between PD-L1 and soluble VEGFR1 in glioblastoma-educated
macrophages.
BMC Cancer. 2023;23:259. PubMedAbstract available
ZHANG M, Liu X, Wang D, Ruan X, et al A novel cuproptosis-related gene signature to predict prognosis in Glioma.
BMC Cancer. 2023;23:237. PubMedAbstract available
CAIN SA, Pope B, Mangiola S, Mantamadiotis T, et al Somatic mutation landscape in a cohort of meningiomas that have undergone grade
progression.
BMC Cancer. 2023;23:216. PubMedAbstract available
XU Z, Hao X, Wang Q, Yang K, et al Intracranial efficacy and safety of furmonertinib 160 mg with or without
anti-angiogenic agent in advanced NSCLC patients with BM/LM as salvage therapy.
BMC Cancer. 2023;23:206. PubMedAbstract available
GEURTS BS, Battaglia TW, van Berge Henegouwen JM, Zeverijn LJ, et al Efficacy, safety and biomarker analysis of durvalumab in patients with
mismatch-repair deficient or microsatellite instability-high solid tumours.
BMC Cancer. 2023;23:205. PubMedAbstract available